{"id":791590,"date":"2026-02-19T14:17:01","date_gmt":"2026-02-19T14:17:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=791590"},"modified":"2026-02-19T14:17:01","modified_gmt":"2026-02-19T14:17:01","slug":"europe-remote-patient-monitoring-rpm-market-to-reach-1122-billion-by-2030-growing-at-103-cagr","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/europe-remote-patient-monitoring-rpm-market-to-reach-1122-billion-by-2030-growing-at-103-cagr_791590.html","title":{"rendered":"Europe Remote Patient Monitoring (RPM) Market to Reach $11.22 billion by 2030, Growing at 10.3% CAGR"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/upload\/2026\/02\/1771494805.jpg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Europe Remote Patient Monitoring (RPM) Market to Reach $11.22 billion by 2030, Growing at 10.3% CAGR\" src=\"https:\/\/www.abnewswire.com\/upload\/2026\/02\/1771494805.jpg\" alt=\"Europe Remote Patient Monitoring (RPM) Market to Reach $11.22 billion by 2030, Growing at 10.3% CAGR\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Europe Remote Patient Monitoring (RPM) Market By Offering {Software [Transmission (synchronous)], Integrated Device (Wearable, Implant, Handheld)}, Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio), End User &#8211; Forecast to 2030<\/div>\n<p style=\"text-align: justify;\">The Europe Remote Patient Monitoring (RPM) Market is experiencing strong momentum as healthcare systems across the region transition toward decentralized, value-based care models. With rising chronic disease prevalence and increasing pressure on hospital infrastructure, RPM solutions are becoming essential for continuous, real-time patient management.<\/p>\n<p style=\"text-align: justify;\">According to market projections, the Europe RPM market is expected to grow from USD 6.87 billion in 2025 to USD 11.22 billion by 2030, registering a CAGR of 10.3% during the forecast period.<\/p>\n<p style=\"text-align: justify;\"><strong>Download PDF Brochure:- <a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=135350894&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=135350894<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Market Growth Drivers<\/strong><\/p>\n<p style=\"text-align: justify;\">The expansion of the Europe RPM market is fueled by several structural and technological factors:<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Shift toward value-based and outcome-driven healthcare delivery<\/p>\n<\/li>\n<li>\n<p>Growing clinician shortages across major European countries<\/p>\n<\/li>\n<li>\n<p>Rising demand for hospital-at-home and virtual ward programs<\/p>\n<\/li>\n<li>\n<p>Expansion of national eHealth and cross-border interoperability frameworks<\/p>\n<\/li>\n<li>\n<p>Increasing chronic multimorbidity among aging populations<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Healthcare providers are increasingly adopting RPM tools to support long-term disease management, reduce hospital readmissions, and optimize care delivery in decentralized settings.<\/p>\n<p style=\"text-align: justify;\"><strong>Wearable Devices Segment Dominated the Market in 2024<\/strong><\/p>\n<p style=\"text-align: justify;\">By offering, wearable devices accounted for the largest market share in 2024. Their dominance is attributed to strong alignment with national virtual care programs and reimbursed digital health pathways.<\/p>\n<p style=\"text-align: justify;\">European providers are increasingly prescribing CE-marked cardiac patches, ambulatory ECG wearables, and activity monitoring sensors for conditions such as:<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Heart failure<\/p>\n<\/li>\n<li>\n<p>Diabetes<\/p>\n<\/li>\n<li>\n<p>Parkinson&rsquo;s disease<\/p>\n<\/li>\n<li>\n<p>Post-stroke rehabilitation<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Countries including Germany and France are integrating validated wearable technologies into reimbursed care frameworks, accelerating widespread adoption. The rise of hospital-supported virtual wards and remote neuromonitoring programs is further strengthening demand for clinician-grade wearable RPM devices.<\/p>\n<p style=\"text-align: justify;\"><strong>Mental Health Segment to Register the Fastest Growth<\/strong><\/p>\n<p style=\"text-align: justify;\">By indication, the mental health segment is projected to grow at the fastest rate during the forecast period.<\/p>\n<p style=\"text-align: justify;\">European healthcare systems are expanding digital-first care pathways for:<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>Depression<\/p>\n<\/li>\n<li>\n<p>Anxiety<\/p>\n<\/li>\n<li>\n<p>Stress-related disorders<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Recent data highlights the scale of the need:<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>A 2023 Eurobarometer survey found that 46% of Europeans experienced emotional or psychosocial issues in the past year.<\/p>\n<\/li>\n<li>\n<p>The WHO European Region reports that one in six people lives with a mental health condition.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">Wider reimbursement of digital mental health tools in Germany and Nordic countries, combined with clinician shortages, is accelerating the adoption of AI-supported behavioral tracking and remote mental health monitoring solutions.<\/p>\n<p style=\"text-align: justify;\"><strong>Germany Led the Market in 2024<\/strong><\/p>\n<p style=\"text-align: justify;\">Germany held the largest share of the Europe RPM market in 2024, driven by its strong regulatory and reimbursement framework.<\/p>\n<p style=\"text-align: justify;\">Key policy enablers include:<\/p>\n<ul style=\"text-align: justify;\">\n<li>\n<p>The Digital Healthcare Act (DVG)<\/p>\n<\/li>\n<li>\n<p>The DiGA fast-track program for reimbursed digital health applications<\/p>\n<\/li>\n<li>\n<p>The Digital Act supporting e-prescriptions and electronic patient records<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">These initiatives have positioned Germany as one of the most supportive regulatory environments in Europe for scaling validated remote monitoring solutions.<\/p>\n<p style=\"text-align: justify;\"><strong>Request For Sample Pages:- <a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=135350894&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=135350894<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Key Market Players<\/strong><\/p>\n<p style=\"text-align: justify;\">The Europe Remote Patient Monitoring market includes several major global healthcare technology providers, including: Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Oracle (US), Boston Scientific Corporation (US), Abbott (US), Nihon Kohden Corporation (Japan), and Siemens Healthineers AG (Germany), among others.<\/p>\n<p style=\"text-align: justify;\"><strong>Strategic Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\">The Europe Remote Patient Monitoring (RPM) market is positioned for sustained double-digit growth through 2030. Strong regulatory support, reimbursement frameworks, wearable device adoption, and the expansion of digital mental health programs are driving demand across the region. As healthcare systems prioritize preventive, home-based, and data-driven care models, RPM technologies are becoming foundational to Europe&rsquo;s evolving healthcare ecosystem.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_145966.html\" rel=\"nofollow\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Rohan Salgarkar<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=europe-remote-patient-monitoring-rpm-market-to-reach-1122-billion-by-2030-growing-at-103-cagr\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>1615 South Congress Ave.  Suite 103, Delray Beach, FL 33445<br \/><strong>City:<\/strong> Florida<br \/><strong>State:<\/strong> Florida<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/europe-remote-patient-monitoring-rpm-market-135350894.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/europe-remote-patient-monitoring-rpm-market-135350894.html<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=europe-remote-patient-monitoring-rpm-market-to-reach-1122-billion-by-2030-growing-at-103-cagr\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Europe Remote Patient Monitoring (RPM) Market By Offering {Software [Transmission (synchronous)], Integrated Device (Wearable, Implant, Handheld)}, Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio), End User &#8211; Forecast to 2030 The Europe Remote Patient Monitoring (RPM) Market is experiencing strong momentum &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/europe-remote-patient-monitoring-rpm-market-to-reach-1122-billion-by-2030-growing-at-103-cagr_791590.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,411,403,404],"tags":[],"class_list":["post-791590","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Technology","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/791590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=791590"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/791590\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=791590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=791590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=791590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}